brexit
New targeted lung cancer treatment coming to UK under MHRA scheme
July 15, 2021MHRA, NSCLC, UK, brexit
The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …
Sickle cell therapy granted innovation passport by MHRA
June 30, 2021Research and Development MHRA, SCD, brexit
Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …
Biosimilars and Brexit: What’s in store for UK’s biosimilar market?
June 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit
It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …
The November 2020 issue of Pharmafocus is available to read free online now!
October 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir
The latest monthly edition of Pharmafocus is available to read for free online now!
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
October 19, 2020Sales and Marketing ABPI, EU, UK, brexit, pharma
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a no-deal scenario with the European …
UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns
August 4, 2020Manufacturing and Production UK, brexit, coronavirus
The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …
Read the January/February 2020 edition of Pharmafocus online now!
January 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
Majority of British people worried about the fate of the NHS in post-Brexit US trade deal, survey reveals
November 28, 2019Medical Communications Boris Johnson, Jeremy Corbyn, NHS, Trump, brexit, european union
In a newly released survey on “Over-The-Counter (OTC) and Pharma 2019”, by the business data platform Statista, 55% of people …
Damage control: How will pharma manage the health economic impacts of Brexit?
October 23, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, brexit, health economics and outcomes research, pharma
When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …
“No deal” Brexit and life sciences: What happens?
October 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Europe, UK, brexit, no deal, no-deal, pharma
Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …
Read the September edition of Pharmafocus online now!
September 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma
The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …
Top Ten most popular articles on Pharmafile.com this week
September 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mylan, brexit
It’s Friday, meaning the weekend is within reach and it’s time for a rundown of the most popular articles on …
Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority
September 5, 2019Medical Communications, Sales and Marketing England, Ireland, UK, brexit, pharma
Though MPs are moving forward with their plan to block UK Prime Minister Boris Johnson’s supposed no-deal Brexit from the …
No-deal Brexit will “make the disintegration of the health service an ever more real prospect”, BMA warns
September 2, 2019Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, NHS, UK, brexit, pharma
As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has …
British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal
August 19, 2019Sales and Marketing EU, UK, US, brexit, brexit delay, healthcare, no-deal, pharma
The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that …
